THE DR. RALPH AND MARIAN FALK MEDICAL RESEARCH TRUST awarded $485,000 to research teams from the Icahn School of Medicine at Mount Sinai and Thomas Jefferson University in Philadelphia to study the effects of key genetic mutations in uveal melanoma. There are no FDA-approved therapies for metastatic UM and patient survival is poor. Julio Aguirre-Ghiso,...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
